oral noncovalent hemoglobin (HbS) modulator

2:1 binding, high RBC partition.; in Ph. I w/ HV

from virtual screening, NMR confirm. and opt.

J. Med. Chem., Dec. 24, 2020

Pfizer, Groton, CT / Cambridge, MA

Structure of PF07059013

Pfizer noncovalent oral hemoglobin (HbS) modulator


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: